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Electron microscopyThe chemotherapeutic agents used for the treatment of giardiasis are often associated with adverse side
effects and are refractory cases, due to the development of resistant parasites. Therefore the search for new
drugs is required. We have previously reported the giardicidal effects of metronidazole (MTZ) and its
analogues (MTZ-Ms, MTZ-Br, MTZ-N3, and MTZ-I) on the trophozoites of Giardia lamblia. Now we evaluated
the activity of some giardicidal MTZ analogues in experimental infections in gerbils and its effects on the
morphology and ultrastructural organization of Giardia. The giardicidal activity in experimental infections
showed ED50 values signiﬁcantly lower for MTZ-I and MTZ-Br when compared to MTZ. Transmission electron
microscopy was employed to approach the mechanism(s) of action of MTZ analogues upon the protozoan.
MTZ analogues weremore active thanMTZ in changing signiﬁcantly themorphology and ultrastructure of the
parasite. The analogues affected parasite cell vesicle trafﬁcking, autophagy, and triggered differentiation into
cysts. These results coupled with the excellent giardicidal activity and lower toxicity demonstrate that these
nitroimidazole derivates may be important therapeutic alternatives for combating giardiasis. In addition, our
results suggest a therapeutic advantage in obtaining synthetic metronidazole analogues for screening of
activities against other infectious agents.Pesquisa do Estado de Minas–
US, CNPq, and FIOCRUZ.
: +55 31 3409 2970.
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Giardia lamblia is a parasitic protozoan that colonizes the human
intestinal tract causing a wide clinical spectrum disorder called
giardiasis. The disease is a zoonosis which is considered an important
public health problem in many countries worldwide. It infects about
200 million people in Asia, Africa, and Latin America (Yason and
Rivera, 2007). G. lamblia is a major cause of diarrhea among children
and travelers (Buret, 2008).
Infected individuals may be asymptomatic or present dehydration-
causing diarrhea and abdominal discomfort. Giardiasis can produce
chronic diarrhea, lasting for several months, which may result in
malabsorption and weight loss, contributing to the increased mortality
of individuals who are malnourished or immune deﬁcient in the ﬁrst 3
years of life (Buret et al., 2002; Ankarklev et al., 2010; Wensaas et al.,
2010; Cotton et al., 2011). Both host and parasite factors contribute to thepathogenesis of giardiasis. Malabsorption, maldigestion, chloride hyper-
secretion, and increased rates of small intestinal transit are the main
factors involved in the onset of diarrhea (Buret, 2008; Cotton et al., 2011).
ThereforeG. lambliahas been implicated in the disturbance of physical
(Farthing et al., 1986; Simsek et al., 2004) and cognitive (Thompson et al.,
1993) development among children. It is estimated that the incidence of
giardiasis in the world reached 1 billion cases, constituting one of the
most common protozoan infection (Wright et al., 2003). Nevertheless,
it is a neglected disease. A variety of chemotherapeutic agents have
been used in the treatment of giardiasis. However, most of the drugs
used display signiﬁcant side effects and are contraindicated in some
cases. Moreover, Giardia is able to develop resistance to these agents
(Wright et al., 2003; Müller et al., 2000). Giardiasis was included in the
‘Neglected Diseases Initiative’ (Savioli et al., 2006) highlighting the
need for new effective nontoxic giardicidal drugs.
The introduction of nitroheterocyclic drugs, in the 1950s, repre-
sented a new era in the treatment of bacterial and protozoan infections.
Metronidazole (1- β-hydroxyethyl-2-methyl-5-nitroimidazole) is cur-
rently themost widely used drug for the treatment of infections caused
by G. lamblia, Entamoeba histolytica, Trichomonas vaginalis, and
Blastocystis spp. (Upcroft and Upcroft, 2001; Busatti et al., 2009; Leitsch
Table 1
Activity in vivo of MTZ analogues against G. lamblia in gerbils.a
Compound ED50 (μmol/kg)b
MTZc 0.74 (0.78–0.72)
MTZ-Br 0.51 (0.53–0.49)
MTZ-I 0.38 (0.42–0.34)
a Results are expressed as mean (n = 6).
b Dose required to inhibit 50% of organism growth with 95% conﬁdence limits.
c Positive control.
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resistance have been documented in all these parasites (Upcroft et al.,
2006; Bansal et al., 2006; Tejman-Yarden et al., 2011), encouraging the
advancement of research on alternative drugs against these parasites.
Metronidazole (MTZ) analogues have been developed and tested
against different microorganisms, and some of them have proved
effective against Giardia, Trichomonas, and Entamoeba histolytica
(Upcroft et al., 2006; Barbosa et al., 2006; Busatti et al., 2007).
Previously, we reported the activity of MTZ analogues against G.
lamblia (Busatti et al., 2007). Here we evaluated the giardicidal
activity of someMTZ analogues in experimentally infected gerbils and
employed an ultrastructural analysis as an instrumental tool to clarify
the mechanisms of action of these potential drugs upon the parasite.
2. Material and methods
2.1. Synthesis of MTZ analogues
MTZ analogues were obtained by reactions as described previously
(Busatti et al., 2007). The purity of these compounds was evaluated by
thin layer chromatography on silica gel plates. The structures were
conﬁrmed by spectral data analysis (RMN1H and RMN13C). The dose–
response curves were obtained by associating axenic cultures of
Giardia with increasing concentrations of MTZ, MTZMs, MTZN3, MTZ-
Br, and MTZI, ranging from 0.08 to 30 μmol/L.
2.2. Cultures and growth conditions
G. lamblia Portland strain (ATCC 30888) was used in all
experiments. It was kept axenically at 37 °C in Diamond's modiﬁed
TYI-S-33 medium (Keister, 1983) supplemented with heat-inacti-
vated bovine serum at 10%. To quantify the drug's action, 1.5 × 105
trophozoites of Giardia were grown in culture plates of 24 wells
(Nunc, Berkeley, CA, USA) in CO2 atmosphere at 37 °C for 48 h.
2.3. Antigiardial activity in vivo
Giardicidal activity, in vivo, of MTZ analogues was assessed by
determining the parasitic load of trophozoites as previously described
(Belosevic et al., 1983; Araújo et al., 2008)with somemodiﬁcations. The
activity of MTZ analogues onGiardia trophozoites was evaluated in vivo
using gerbils (Meriones unguiculatus) as an experimental model. The
experiments were performed in compliance with the guidelines of the
Institutional Animal Care and Committee on Ethics of Animal
Experimentation (Comitê de Ética em Experimentação Animal–
CETEA, national guidelines Lei 11.794, de 8 de outubro de 2008) of
Universidade Federal de Minas Gerais (UFMG; protocol number 181/
2008, approved on 03/04/2009). Animals aged 4–8 weeks of both sexes
were used. They were divided into groups of 6 animals for each
compound: a negative control group (in the absence of nitroimida-
zoles), a group that received the vehicle (phosphate buffered saline
[PBS, pH 7.2], containing dimethyl sulfoxide [DMSO, 0.05%]); a positive
control group (in the presence of metronidazole); and 5 test groups,
where animals infected with G. lamblia were treated with 0.1 to 6.0
μmol/kg of MTZ and its analogues, MTZ-I and MTZ-Br.
For the inhibition assay, 1 × 106 G. lamblia trophozoites in 1 mL of
PBS were inoculated in gerbils by gavage. Six days after inoculation,
the animals were treated intragastrically with 1 mL of the nitroimi-
dazoles, dissolved in PBS containing 0.05% DMSO. Two days after the
treatment with drugs (8 days after inoculation), the animals were
sacriﬁced and 18 cm of the small intestine of each animal was
removed, opened longitudinally, and placed in glass tubes containing
10 mL of cold PBS for 20 min. ED50, which is the dose leading to 50%
parasite growth inhibition, compared to growth in the control, was
determined for each compound.2.4. Transmission electron microscopy
Parasites were ﬁxed in 4% paraformaldehyde (Polysciences,
Warrington, PA, USA), 2.5% glutaraldehyde (Polysciences), 4% sucrose
in 0.1 mol/L sodium cacodylate buffer (pH 7.2) for at least 1 h, post-
ﬁxed in 1% osmium tetroxide (Polysciences) and 0.8% potassium
ferricyanide in the same buffer for 40 min, dehydrated in acetone
series, and embedded in Polybed resin (Polysciences). Thin sections
were stained with 2% uranyl acetate for 20 min and with 1% lead
citrate for 5 min and observed under a Zeiss 900 transmission electron
microscope (Carl-Zeiss, Oberkochen, Germany).
The morphometric analysis of peripheral vesicles of trophozoites
was performed before and after MTZ-I treatments. The area
determination was made based on the limits of these organelles,
using the software SIS iTEM (SIS iTEM, Palatka, FL, USA). Three
vesicles per cell were selected randomly on at least 20 cells
observed on ultrathin sections. The data plotted in GraphPad Prism
5.0 (GraphPad, San Diego, CA, USA) are represented as the mean ±
SEM and were analyzed by Student's t test with a signiﬁcance level
of P b 0.05.
2.5. Statistical analysis
Each experiment was done at least 3 times in triplicate. Analysis of
variance (ANOVA)was used to analyze differences between IC50 (dose
required for 50% growth inhibition in vitro) and ED50 (dose required
to inhibit 50% of organisms growth in vivo) values. P values below
0.05 were considered statistically signiﬁcant.
3. Results
3.1. Antigiardial activity
The IC50 of MTZ-Ms (0.69 ± 0.05), MTZ-N3 (0.70 ± 0.16), MTZ-I
(0.40 ± 0.03), and MTZ-Br (0.28 ± 0.04) tested presented higher
giardicidal activity when compared with MTZ (1.96 ± 0.13). MTZ-Br
and MTZ-I were the most active (P b 0.001), so they were chosen to
determine the antigiardial activity in vivo.
Both the MTZ analogues MTZ-I and MTZ-Br were able to
signiﬁcantly (P b 0.001) reduce the G. lamblia parasite load in infected
gerbils. MTZ-Br and MTZ-I had greater giardicidal activity, with ED50
values signiﬁcantly lower than the MTZ (Table 1).
3.2. Transmission electron microscopy
Ultrastructural analysis of untreated control G. lamblia trophozoite
ﬁxed after 48 h of incubation in the presence of 0.05% DMSO did not
induce alterations in the ultrastructure of the protozoan (Fig. 1A),
indicating that this solvent concentration was nontoxic.
Trophozoites incubated with MTZ showed evident ultrastruc-
tural disorganization (Fig. 1B) characterized by the centripetal
displacement of the peripheral vesicles and internalization of the
cytoskeletal components of the ﬂagella and adhesive disk into
the cytoplasmic matrix.
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Fig. 1. (A) Cross section of Giardia lamblia trophozoite incubated with 0.05% DMSO showing characteristic ultrastructure, with the presence of peripheral vesicles (*), endoplasmic
reticulum cisternae (white arrows), nucleus (N), adhesive disk (black arrows), and axonemes of the ﬂagella (arrowheads) within the homogeneously electron-dense cytoplasm. (B)
G. lamblia trophozoites incubated with 0.85 μmol/L of metronidazole for 48 h, with ultrastructural disorganization, centripetal displacement of peripheral vesicles (*), and ﬂagellar
internalization (arrowhead) as well as numerous cytoplasmic axonemes (arrows). (C) Trophozoites incubated for 48 h in the presence of 0.51 μmol/L of metronidazole-N3 displaying
peripheral vesicle dilatation and interdigitation (black arrow), as well as concave regions of adhesion disk engulfment areas (arrowheads) and disassembly of its cytoskeleton
components (white arrow). (D) Trophozoites incubated for 48 h in the presence of 0.51 μmol/L of metronidazole-N3 displaying the formation of extensive concentric arrays of
endoplasmic reticulum cisternae (arrowhead) circumscribing the nuclei (N). (E) Cells incubated for 48 h in the presence of 0.48 mmol/L of metronidazole-MS showed marked
disorganization of the cellular architecture of trophozoites and internalization of the ﬂagella (black arrow), adhesive disk (arrowhead), and its components' disassembly (white
arrow). (F) We also observed a lower cytoplasmic electrondensity and the absence of glycogen granules. (G) and (H) G. lamblia trophozoites treated with 0.32 μmol/L of
metronidazole-Br for 48 h. We observed internalization and disaggregation of adhesive disk cytoskeleton components (G, arrow), heterogeneous cytoplasmic granulosity, and
electrondensity properties as many parasites displayed remarkable cytoplasmic extraction (H), resulting in altered cell architecture. (I) and (J) G. lamblia trophozoites treated with
0.26 μmol/L of metronidazole-I displayed remarkably swollen vesicles (I, *), which may be involved in the internalization of the ﬂagella (arrow). Morphometry of the peripheral
vesicles revealed that the average area in the 0.26 μmol/L metronidazole-I–treated images was signiﬁcantly (***, P b 0.001) enhanced (I, inset). Several cells presented autophagic
process (J), characterized by concentric membranes (arrowhead) surrounding the cytoplasmic material presumably in degradation.
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disk internalization and peripheral vesicle interdigitation (Fig. 1C).
Several cells presented multilayered membranes stacked in the peri-
nuclear area (Fig. 1D).
Altered parasite cell architecture and adhesive disk internaliza-
tion were also found in trophozoites incubated with MTZ-Ms
(Fig. 1E). Lower cytoplasmic electrodensity and absence ofglycogen granules were also observed (Fig. 1F). Heterogeneous
cytoplasmic granulosity and electrondensity properties were ob-
served in Giardia trophozoites treated with 0.32 μmol/L metroni-
dazole-Br for 48 h (Fig. 1G), as well as internalization of adhesive
disk cytoskeleton components (arrowhead). Many parasites dis-
played remarkable cytoplasmic extraction (Fig. 1H), resulting in
altered cell architecture.
163H.GNO. Busatti et al. / Diagnostic Microbiology and Infectious Disease 75 (2013) 160–164Parasites grown in the presence of MTZ-I presented remarkably
large vesicles, which may be involved in the internalization of the
ﬂagella (Fig. 1I). Morphometric analysis of 0.26 μmol/L of MTZ-I–
treated parasites revealed 3-fold (P b 0.001) enlargement of sectioned
peripheral vesicle areas as compared to controls (Fig. I, insert).
Autophagic vacuole formation surrounding the cytoplasmic material
presumably in degradation was also observed (Fig. 1J).
4. Discussion
Despite its signiﬁcant morbidity causing considerable socioeco-
nomic impact, especially in underdeveloped countries, giardiasis is
largely overlooked.
Besides sanitation, disease control could be accomplished by
vaccination (Olson et al., 2000) and with new drugs to avoid the
resistance phenomenon (Argüello-García et al., 2009; Leitsch et al.,
2011). MTZ analogues are efﬁcient giardicidal compounds and could
become an alternative for the treatment of giardiasis (Upcroft et al.,
2006; Busatti et al., 2007). Thus, we evaluated the giardicidal activity
of some MTZ analogues in experimentally infected gerbils and its
effects on the morphology and ultrastructural organization of Giardia.
All analogues tested displayed higher anti-Giardia activity than the
MTZ. The analogues were able to signiﬁcantly reduce the parasite load
of gerbils infected with G. lamblia. In an electrochemical study, these
analogues showed greater reduction potential for MTZ-Br followed by
MTZ-I and MTZ (Cavalcanti et al., 2004). These results highlight the
reduction potential as a chemical giardicidal property relevant to the
activity of these compounds. Reduction leads to the formation of toxic
nitro radicals, which are responsible for the destabilization of DNA
and the production of other toxic radicals that react with essential
cellular components, interfering with cellular metabolism (Edwards,
1993; Leitsch et al., 2011).
The transmission electron microscopy revealed that trophozoites
of G. lamblia treated with MTZ and its analogues showed a marked
change in cellular architecture with evident ultrastructural disorga-
nization. Trophozoites treated with the analogues showed changes
similar to those observed in parasites treated with MTZ, such as
centripetal displacement of the peripheral vesicles, internalization of
the ﬂagella and cytoskeletal components of the adhesive disk,
vacuolization, and dilation and extraction of peripheral cytoplasmic
vesicles, indicating that themechanisms of action of these compounds
caused similar metabolic changes in the parasite.
Antiparasitic drugs may affect the protozoa endocytic (Bernardes
et al., 2000) and/or autophagic pathways (Vannier-Santos et al., 1999;
Vannier-Santos and de Castro, 2009). The formation of concentric
membranes and myelin ﬁgures is indicative of autophagic processes;
these changes were particularly observed in trophozoites treatedwith
MTZ-I analogues. The engulfment of digit-form processes between
adjacent peripheral vesicles might characterize microautophagy
triggering as vacuolar tubular invaginations may be involved in
autophagy (Müller et al., 2007). Interestingly, the Giardia lysosomal
functions may be performed by endoplasmic reticulum–like tubulo-
vesicular compartments (Abodeely et al., 2009). The formation of such
concentric cisternae in the perinuclear area may be related to the
endoplasmic reticulum nature of the nuclear envelop. In this regard, it
is noteworthy that herpes simplex virus 1–induced autophagymay be
associated with the formation of concentric cisternae from the
macrophage nuclear envelope (English et al., 2009). The internaliza-
tion of the ﬂagella and adhesion disk components is presumably
associated with parasite encystment due to the drug-induced stress
(Maia et al., 2008).
In previous studies, we observed that the analogues of MTZ were
not cytotoxic in vitro to human cells in a concentration range from 0.2
to 6.4 μmol/L (Busatti et al., 2007). These results coupled with the
excellent giardicidal activity in vivo and in vitro demonstrate that
these nitroimidazole derivates may be important therapeutic alter-natives to combat giardiasis. Furthermore, the present results suggest
a therapeutic advantage with obtaining synthetic analogues of MTZ
for screening of activities against other infectious agents.References
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